ACCESSWIRE
11 Jun 2019, 07:55 GMT+10
ST. PETERSBURG, FL / ACCESSWIRE / June 10, 2019 / MMJ BioPharma Cultivation, a premier medical cannabis cultivation and research company today announced that it has signed a memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis and supply active pharmaceutical ingredients (API) for its drug product MMJ-001 and MMJ-002.
MMJ BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana plant to support its investigational new drug (IND) filings with the FDA for Multiple Sclerosis and Huntington's disease. It will also plan to meet the growing demand from hospitals, researchers, and scientist for their FDA/DEA approved clinical trials.
MMJ BioPharma Cultivation has applied for a DEA Schedule-I Bulk Manufacturer license to cultivate cannabis plants for this purpose. MMJ BioPharma Cultivation will facilitate a process of scientific drug development and discovery governed by FDA protocol development processes and DEA regulatory manufacturing guidelines.
To further meet the statutory requirements of the 'public benefit' MMJ BioPharma Cultivation has entered into an agreement with a US Native Indian Tribe to perform its development activities. MMJ BioPharma Cultivation is planning a phased development program of approximately 1 million square feet with a state of the art extraction analytics lab to meet DEA approved researchers needs. MMJ BioPharma Cultivation will be employing tribal members in its development and cultivation program.
Dr. Elio Mariani, a senior executive of the company and big pharma veteran stated 'we are looking forward to our collaboration with others in unlocking the potential of cannabinoid medicines to address serious medical conditions. Our efforts will be guided by the FDA, DEA as we strive to produce the highest pharma grade plants and extracts for clinical research.'
About the Company: http://mmjbiopharmacultivation.com
MMJ Biopharma Cultivation combines decades of cultivation, life science and drug development experience with industry-leading expertise in cannabinoid science. Our focus is growing pharma grade marijuana, developing and commercializing proprietary cannabinoid-derived medicines that address significant patients unmet needs.
CONTACT:
Michael Sharpe
800-586-7863
media@mmjih.com
SOURCE: MMJ BioPharma Cultivation
Get a daily dose of The US News news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to The US News.
More InformationNEW DELHI, India - India and China have agreed to push for an early disengagement of the frontline troops in ...
PanARMENIAN.Net - There is some evidence that a new coronavirus variant first identified in southeast England carries a higher risk ...
AMSTERDAM, Netherlands - A Canadian man, one of the world's most wanted fugitives, has been arrested by the Central Unit ...
LOS ANGELES, California (ANI/Big News Network) - American award-winning TV and radio host Larry King, who became a household name ...
PanARMENIAN.Net - Hong Kong's government declared its first lockdown on Saturday, ordering thousands of people to stay in their homes ...
Geneva [Switzerland], January 26 (ANI): The executive director of the World Health Organization's (WHO) Health Emergencies Programme, Mike Ryan, has ...
NEW YORK, New York - Wall Street got the wobbles on Monday after a sell-off in Europe and the UK. ...
Washington [US], January 25 (ANI): Potterheads have a reason to rejoice as a new 'Harry Potter' television series is currently ...
SYDNEY, NSW, Australia - Stocks hit the floor running on Monday in a positive start to the new week.Futures trading ...
The massive campaign organized by India's farmers against laws to deregulate the agricultural sector has entered its ninth week. The ...
Dutch airline KLM is to lay off up to another 1,000 people, following the 5,000 job losses of last year.Like ...
ALBUQUERQUE, New Mexico - Nearly 60 percent of residents rate Albuquerque's quality of life as excellent or good, according to ...